[Pharmacological study on an irreversible ligand of opioid receptors- 7 alpha-bis (beta-chloroethyl) amino-6, 14-endoetheno-tetrahydrooripavine (alpha-CAO)].
D000700:Analgesics; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites; D006168:Guinea Pigs; D008024:Ligands; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism; D013797:Thebaine / Q000031:analogs & derivatives* / Q000494:pharmacology
D000700:Analgesics; D000701:Analgesics, Opioid; D008024:Ligands; D011957:Receptors, Opioid; D013797:Thebaine; C053349:7-(N,N-bis(2-chloroethyl)amino)-6,14-endoethenotetrahydrooripavine